Literature DB >> 12362993

A comparison between the crystal and solution structures of Escherichia coli asparaginase II.

Maciej Kozak1, Stefan Jurga.   

Abstract

The small angle X-ray scattering (SAXS) pattern of the homotetrameric asparaginase II from Escherichia coli was measured in solution in conditions resembling those in which its crystal form was obtained and compared with that calculated from the crystallographic model. The radius of gyration measured by SAXS is about 5% larger and the maximum dimension in the distance distribution function about 12% larger than the corresponding value calculated from the crystal structure. A comparison of the experimental and calculated distance distribution functions suggests that the overall quaternary structure in the crystal and in solution are similar but that the homotetramer is less compact in solution than in the crystal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362993

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  10 in total

1.  L-Asparaginase from Erwinia carotovora: insights about its stability and activity.

Authors:  Marcele Faret; Stephanie Bath de Morais; Nilson Ivo Tonin Zanchin; Tatiana de Arruda Campos Brasil de Souza
Journal:  Mol Biol Rep       Date:  2018-11-16       Impact factor: 2.316

2.  Protein Footprinting and X-ray Crystallography Reveal the Interaction of PD-L1 and a Macrocyclic Peptide.

Authors:  Ben Niu; Todd C Appleby; Ruth Wang; Mariya Morar; Johannes Voight; Armando G Villaseñor; Sheila Clancy; Sarah Wise; Jean-Philippe Belzile; Giuseppe Papalia; Melanie Wong; Katherine M Brendza; Latesh Lad; Michael L Gross
Journal:  Biochemistry       Date:  2019-12-31       Impact factor: 3.162

3.  Aliivibrio fischeri L-Asparaginase production by engineered Bacillus subtilis: a potential new biopharmaceutical.

Authors:  Heitor B S Bento; Gabriela B Paiva; Mafalda R Almeida; Claúdia G Silva; Pedro J Carvalho; Ana P M Tavares; Danielle B Pedrolli; Valéria C Santos-Ebinuma
Journal:  Bioprocess Biosyst Eng       Date:  2022-08-16       Impact factor: 3.434

4.  Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I.

Authors:  Mi-Kyung Yun; Amanda Nourse; Stephen W White; Charles O Rock; Richard J Heath
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

5.  A new level of architectural complexity in the human pyruvate dehydrogenase complex.

Authors:  Michaela Smolle; Alison Elizabeth Prior; Audrey Elaine Brown; Alan Cooper; Olwyn Byron; John Gordon Lindsay
Journal:  J Biol Chem       Date:  2006-05-05       Impact factor: 5.157

6.  Low-resolution structure of the full-length barley (Hordeum vulgare) SGT1 protein in solution, obtained using small-angle X-ray scattering.

Authors:  Michał Taube; Joanna R Pieńkowska; Artur Jarmołowski; Maciej Kozak
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 7.  Current applications and different approaches for microbial l-asparaginase production.

Authors:  Jorge Javier Muso Cachumba; Felipe Antonio Fernandes Antunes; Guilherme Fernando Dias Peres; Larissa Pereira Brumano; Júlio César Dos Santos; Silvio Silvério Da Silva
Journal:  Braz J Microbiol       Date:  2016-10-27       Impact factor: 2.476

8.  Metagenomic discovery and functional validation of L-asparaginases with anti-leukemic effect from the Caspian Sea.

Authors:  Motahareh Sobat; Sedigheh Asad; Mahboubeh Kabiri; Maliheh Mehrshad
Journal:  iScience       Date:  2021-01-05

9.  Purification and Characterization of Asparaginase from Phaseolus vulgaris Seeds.

Authors:  Saleh A Mohamed; Mohamed F Elshal; Taha A Kumosani; Alia M Aldahlawi
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

Review 10.  Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions.

Authors:  Marina V Pokrovskaya; Vadim S Pokrovsky; Svetlana S Aleksandrova; Nikolay N Sokolov; Dmitry D Zhdanov
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.